ESC 365 - Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study

ESC Premium Access

Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study

Session: Poster Session 7 - Atrial fibrillation - Ablation

Topic: Treatment

Speaker: Doctor T. Yonishi (Osaka, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Tomoka Yonishi

Osaka University Graduate School of Medicine, Osaka (Japan)

0 follower

19 more presentations in this session

Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.

Speaker: Doctor V. Orshanskaya (Saint Petersburg, RU)

High-normal thyroid-stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation for atrial fibrillation

Speaker: Doctor I. Morishima (Ogaki, JP)

Improvement in quality of life in patients that underwent catheter ablation for persistent atrial fibrillation.

Speaker: Doctor K. Nakajima (Tokyo, JP)

Association of coronary artery disease and revascularization with recurrence of atrial fibrillation after catheter ablation

Speaker: Doctor D. Hiraya (Tsukuba, JP)

Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument

Speaker: Doctor A. Bjorkenheim (Orebro, SE)

Access the full session

Poster Session 7 - Atrial fibrillation - Ablation

Speakers: Doctor T. Yonishi, Doctor V. Orshanskaya, Doctor I. Morishima, Doctor K. Nakajima, Doctor D. Hiraya...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources